Quick Links

 Cancer Center Leadership

Michael A. Friedman, M.D.

Michael A. Friedman, M.D.
Director
626-256-4673, ext. 68460
mfriedman@coh.org

Theodore G. Krontiris, M.D., Ph.D.

Theodore G. Krontiris, M.D., Ph.D.
Director Emeritus
626-256-4673, ext. 65085
tkrontiris@coh.org

Richard Jove, Ph.D.

Richard Jove, Ph.D.
Deputy Director for Basic Research
626-256-4673, ext. 62357
rjove@coh.org

Alexandra Levine, M.D., M.A.C.P.

Alexandra Levine, M.D., M.A.C.P.
Medical Director
626-256-4673, ext. 60213
alevine@coh.org

John A. Zaia, M.D.

John A. Zaia, M.D.
Deputy Director for Clinical Research
626-256-4673, ext. 67149
jzaia@coh.org

Amy Barach

Amy Barach
Associate Director for Administration
626-256-4673, ext. 32630
abarach@coh.org

Smita Bhatia, M.D., M.P.H.

Smita Bhatia, M.D., M.P.H.
Associate Director for Population Research
626-256-4673, ext. 67321
sbhatia@coh.org

Linda H. Malkas, Ph.D.

Linda H. Malkas, Ph.D.
Associate Director for Basic Science
626-256-4673, ext. 68423
lmalkas@coh.org

Joyce C. Niland, Ph.D.

Joyce C. Niland, Ph.D.
Associate Director for Information Sciences
626-256-4673, ext. 63032
jniland@coh.org

Douglas Stahl, Ph.D., M.B.A.

Douglas Stahl, Ph.D., M.B.A.
Vice President - Clinical Research Operations
626-256-4673, ext. 64289
dstahl@coh.org

Yun Yen, M.D., Ph.D.

Yun Yen, M.D., Ph.D.
Associate Director for Translational Research
626-256-4673, ext. 65707
yyen@coh.org

 Cancer Center Program Co-leaders

Ravi Bhatia, M.D.

Ravi Bhatia, M.D.
Co-leader, Hematologic Malignancies
626-256-4673, ext. 62705
rbhatia@coh.org

Smita Bhatia, M.D., M.P.H.

Smita Bhatia, M.D., M.P.H.
Co-leader, Cancer Control and Population Sciences
626-256-4673, ext. 67321
sbhatia@coh.org

Stephen J. Forman, M.D., F.A.C.P.

Stephen J. Forman, M.D., F.A.C.P.
Co-leader, Hematologic Malignancies
626-256-4673, ext. 62403
sforman@coh.org

David Horne, Ph.D.

David Horne, Ph.D.
Co-leader, Developmental Cancer Therapeutics
626-256-4673, ext. 67310
dhorne@coh.org

Linda H. Malkas, Ph.D.

Linda H. Malkas, Ph.D.
Co-leader, Molecular Oncology
626-256-4673, ext. 68423
lmalkas@coh.org

Susan L. Neuhausen, Ph.D.

Susan L. Neuhausen, Ph.D.
Co-leader, Cancer Control and Population Sciences
626-256-4673, ext. 69261
sneuhausen@coh.org

Andrew Raubitschek, M.D.

Andrew Raubitschek, M.D.
Co-leader, Cancer Immunotherapeutics
626-256-4673, ext. 62451
araubitschek@coh.org

Binghui Shen, Ph.D.

Binghui Shen, Ph.D.
Co-leader, Molecular Oncology
626-256-4673, ext. 64150
bshen@coh.org

Yun Yen, M.D., Ph.D.

Yun Yen, M.D., Ph.D.
Co-leader, Developmental Cancer Therapeutics
626-256-4673, ext. 65707
yyen@coh.org

Hua Yu, Ph.D.

Hua Yu, Ph.D.
Co-leader, Cancer Immunotherapeutics
626-256-4673, ext. 63365
hyu@coh.org

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.